Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stephen Kubaska

Vascular Surgery Anaheim, CA Medical Doctor

NPI 1952481160 CMS profile 89013

1211 W. La Palma Avenue, Suite 505, Anaheim, CA 92801

Open in the dashboard

General payments

$8,964

165 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stephen Kubaska of Anaheim, CA is reported in the CMS Open Payments database as having received $8,964 across 165 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,296 38
2024 General $1,661 34
2023 General $486 13
2022 General $1,063 11
2021 General $972 25
2020 General $416 12
2019 General $2,070 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Kubaska
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Stephen Kubaska were reported at $2,296. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Stephen Kubaska Vascular Surgery median Middle half National median
2019 $2,070 $796 $226–$2,363 $163
2020 $416 $348 $118–$1,110 $114
2021 $972 $471 $158–$1,421 $132
2022 $1,063 $725 $222–$2,183 $149
2023 $486 $836 $257–$2,440 $160
2024 $1,661 $909 $252–$2,619 $164
2025 $2,296 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $2,467 29 payments
  2. Medtronic, Inc. $1,323 30 payments
  3. Silk Road Medical, Inc. $1,086 12 payments
  4. Cook Medical LLC $1,030 16 payments
  5. Janssen Pharmaceuticals, Inc $298 14 payments
  6. Penumbra, Inc. $296 2 payments
  7. Shockwave Medical, Inc $289 3 payments
  8. Pfizer Inc. $258 9 payments
  9. Abbott Laboratories $221 3 payments
  10. Boston Scientific Corporation $167 3 payments
  11. Other $1,527 44 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,661 162 payments
  2. Consulting Fee $270 2 payments
  3. Travel and Lodging $32 1 payment
Products named General payments · program years 2019–2025
  1. ENROUTE Transcarotid Stent $1,086 12 payments
  2. ENROUTE Transcarotid Neuroprotection System $1,086 12 payments
  3. ENDURANT IIS $1,002 22 payments
  4. C3 Delivery System $700 5 payments
  5. GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis $466 5 payments
  6. ENHANCE Transcarotid Peripheral Access Kit $377 5 payments
  7. ENROUTE .014 Guidewire $377 5 payments
  8. XARELTO $316 15 payments
  9. EXCLUDER AAA Endoprosthesis $290 4 payments
  10. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $289 3 payments
  11. Other $6,078 137 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

165 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record